tiprankstipranks
Clearside Biomedical (CLSD)
NASDAQ:CLSD

Clearside Biomedical (CLSD) Financial Statements

889 Followers

Clearside Biomedical Financial Overview

Clearside Biomedical's market cap is currently ―. The company's EPS TTM is $-0.543; its P/E ratio is -2.34; Clearside Biomedical is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 230.00K$ 6.34M$ 859.00K$ 1.02M$ 4.00K
Gross Profit$ 230.00K$ 6.34M$ 717.00K$ 805.00K$ 4.00K
EBIT$ -9.36M$ -2.56M$ -6.64M$ -6.81M$ -7.11M
EBITDA$ -9.33M$ -2.54M$ -6.63M$ -6.80M$ -7.10M
Net Income Common Stockholders$ -11.76M$ -4.83M$ -9.27M$ -9.11M$ -9.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 35.40M$ 28.90M$ 28.80M$ 35.00M$ 41.40M
Total Assets$ 40.14M$ 34.02M$ 34.42M$ 39.18M$ 44.70M
Total Debt$ 939.00K$ 1.01M$ 1.09M$ 1.16M$ 1.22M
Net Debt$ -34.46M$ -27.89M$ -27.71M$ -33.84M$ -40.18M
Total Liabilities$ 61.95M$ 49.93M$ 47.27M$ 44.16M$ 41.99M
Stockholders Equity$ -21.81M$ -15.91M$ -12.85M$ -4.97M$ 2.70M
Cash Flow-
Free Cash Flow$ -7.91M$ 375.00K$ -6.52M$ -6.44M$ -7.33M
Operating Cash Flow$ -7.85M$ 495.00K$ -6.08M$ -5.34M$ -7.22M
Investing Cash Flow$ -57.00K$ -120.00K$ -445.00K$ -1.10M$ -115.00K
Financing Cash Flow$ 14.34M$ -257.00K$ 317.00K$ 22.00K$ 332.00K
Currency in USD

Clearside Biomedical Earnings and Revenue History

Clearside Biomedical Debt to Assets

Clearside Biomedical Cash Flow

Clearside Biomedical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis